ROR1 and ovarian cancer: Notably, Kaplan–Meier survival analysis found that low ROR1 expression was significantly associated with poor patient prognosis, a result that is contrary to most studies that have partially demonstrated poor prognosis in patients with high ROR1 expression, such as ovarian cancer (43), colorectal cancer (44), and so on.